Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Newtyn Management, LLC

Q3 2023 · 13F-HR

Newtyn Management, LLCholdings as filed

Filed 2023-11-14 · accession 0001493152-23-041042

$405.2M
Reported value
46
Positions
2023-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
13765N107CNNECANNAE HLDGS INC$53.5M13.2%2,868,411CommonSOLE
44891N208IACIAC INC$46.9M11.6%930,000CommonSOLE
698884103PARPAR TECHNOLOGY CORP$37.9M9.35%982,527CommonSOLE
590328209MACKEURMERRIMACK PHARMACEUTICALS IN$23.1M5.70%1,873,694CommonSOLE
L02235106AMBPARDAGH METAL PACKAGING S A$22.5M5.55%7,188,138CommonSOLE
36237H101GIIIG III APPAREL GROUP LTD$20.4M5.04%818,816CommonSOLE
84790A105SPBSPECTRUM BRANDS HLDGS INC NE$19.6M4.83%249,937CommonSOLE
11040G103VTOLBRISTOW GROUP INC$19.5M4.82%692,896CommonSOLE
G8807B106TBPHTHERAVANCE BIOPHARMA INC$15.9M3.92%1,841,560CommonSOLE
178587101CIOCITY OFFICE REIT INC$13.5M3.34%3,180,000CommonSOLE
901384107TSVT*2SEVENTY BIO INC$12.1M2.98%3,076,490CommonSOLE
366505105GTXGARRETT MOTION INC$10.5M2.60%1,335,572CommonSOLE
55262C100MBIMBIA INC$10.3M2.54%1,425,000CommonSOLE
36315X101LKFTGALAPAGOS NV$9.5M2.34%275,000CommonSOLE
05603E208BVFLBV FINL INC$8.9M2.19%879,341CommonSOLE
23284P103CYTEIR THERAPEUTICS INC$7.1M1.75%2,500,444CommonSOLE
65342T106NODKNI HLDGS INC$6.0M1.49%470,000CommonSOLE
34984VAC4FORUM ENERGY TECHNOLOGIES IN$5.4M1.33%5,483,872CommonSOLE
886885102TLYSTILLYS INC$5.4M1.33%662,247CommonSOLE
717098206PFSWEB INC$5.3M1.31%711,953CommonSOLE
71722W107PHATPHATHOM PHARMACEUTICALS INC$5.2M1.28%500,000CommonSOLE
34984V209FETFORUM ENERGY TECHNOLOGIES IN$4.4M1.09%183,300CommonSOLE
69331C108PCGPG&E CORP$4.3M1.07%268,921CommonSOLE
85512G106STHOSTAR HLDGS$4.1M1.01%326,472CommonSOLE
015658107ASTLALGOMA STL GROUP INC$4.0M0.99%590,899CommonSOLE
282559103ETNBGBP89BIO INC$3.1M0.76%200,500CommonSOLE
05455M100AVROBIO INC$3.1M0.76%2,000,000CommonSOLE
Y95308105WVEWAVE LIFE SCIENCES LTD$2.9M0.72%510,000CommonSOLE
50015M109KODKODIAK SCIENCES INC$2.9M0.71%1,608,694CommonSOLE
25065K104DXLGDESTINATION XL GROUP INC$2.7M0.66%600,000CommonSOLE
68629Y103ONLORION OFFICE REIT INC$2.5M0.61%474,721CommonSOLE
68062P106OLMAOLEMA PHARMACEUTICALS INC$1.9M0.46%150,000CommonSOLE
03748R747AIVAPARTMENT INVT & MGMT CO$1.6M0.39%231,865CommonSOLE
00773U108ADVMCHFADVERUM BIOTECHNOLOGIES INC$1.5M0.38%1,025,000CommonSOLE
81728A108SNSEEURSENSEI BIOTHERAPEUTICS INC$1.4M0.33%1,800,000CommonSOLE
38870X104GRPHGRAPHITE BIO INC$1.3M0.33%542,637CommonSOLE
04683R106AVIRATEA PHARMACEUTICALS INC$1.2M0.30%400,000CommonSOLE
097702104BOLT1EURBOLT BIOTHERAPEUTICS INC$1.1M0.26%1,020,000CommonSOLE
59045L106MERSANA THERAPEUTICS INC$889,0000.22%700,000CommonSOLE
01626L105ALIGOS THERAPEUTICS INC$687,2400.17%920,000CommonSOLE
00211Y506ABIOEURARCA BIOPHARMA INC$603,0000.15%300,000CommonSOLE
09203E105BDTXBLACK DIAMOND THERAPEUTICS I$588,3500.15%205,000CommonSOLE
G1643W137BRILLIANT ACQUISITION CORP$95,5980.02%457,409CommonSOLE
040450124ARISZ ACQUISITION CORP$22,5000.01%250,000CommonSOLE
52178J113LFLYWLEAFLY HOLDINGS INC$19,0390.00%634,640CommonSOLE
92853V122VIVEON HEALTH ACQUISITION CO$12,7500.00%250,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.